Hemophilus Meningitis Vaccine Proven to Cause Diabetes in Clinical Trial of Over 100,000 Children; Many Diabetics Eligible for Compensation

Vaccination News Home Page

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-31-2002/0001774731&EDATE=

Today's News
Hemophilus Meningitis Vaccine Proven to Cause Diabetes in Clinical Trial of Over 100,000 Children; Many Diabetics Eligible for Compensation

 

    BALTIMORE, July 31 /PRNewswire/ -- The prestigious peer reviewed journal
Autoimmunity published data this week by Dr. J. Bart Classen, an immunologist
at Classen Immunotherapies, and David Carey Classen, an infectious disease
specialist at the University of Utah, proving a causal relationship between
the hemophilus vaccine and the development of insulin dependent diabetes.  The
data is particularly disturbing because it indicates the risks of the vaccine
exceeds the benefit.  The findings are expected to allow may diabetics to
receive compensation for their injuries and lead to safer immunization.
    The study followed over 100,000 children which had been randomized in a
large clinical trial to receive 1 or 4 doses of the hemophilus vaccine and
over 100,000 unvaccinated children.  After 7 years the group receiving 4 doses
of the vaccine had a statistically significant 26% elevated rate of diabetes,
or an extra 54 cases/100,000 children, compared to children who did not
receive the vaccine.  By contrast immunization against hemophilus is expected
to prevent only 7 deaths and 7 to 26 cases of permanent disability per
100,000 children immunized.  The study showed that almost all of the extra
cases of diabetes caused by the vaccine occurred between 3-4 years after
vaccination.  Furthermore the paper provides new data proving the vaccine
causes diabetes in mice and reviews data from 3 smaller human studies, which
all had similar results to the current study, but were too small to reach
statistical significance.
    "Our results conclusively prove there is a causal relationship between
immunization schedules and diabetes.  We believe immunization schedules can be
made safer," stated Dr. Bart Classen.
    The Classens' research is already becoming widely accepted.  An
independent group of researchers working at a prestigious Swedish medical
center recently published a paper (Ann. N.Y. Acad Sci.  958: 293-296, 2002)
supporting their findings.  Last year doctors attending a conference of the
American College for Advancement in Medicine overwhelmingly agreed that
vaccines can cause chronic diseases such as diabetes.  For the latest
information on the effects of vaccines on insulin dependent diabetes and other
autoimmune diseases visit the Vaccine Safety Web site (http://vaccines.net) .

                        Classen Immunotherapies, Inc.
          6517 Montrose Avenue        Baltimore, MD  21212  U.S.A.
          Tel: (410) 377-4549         Fax: (410) 377-8526
          Classen@vaccines.net        http://vaccines.net

Click here
 
SOURCE Classen Immunotherapies, Inc.
Web Site: http://vaccines.net
 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.

Copyright © 1996-2002 PR Newswire Association LLC. All Rights Reserved.
A United Business Media company.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.